Replies to post #232471 on Bioelectronics Corp (BIEL)

[GetSeriousOK]

Let's say there's a PR tomorrow, OEM Partner signed.

When's the earliest this new Partner can get the product on the shelves? "Soon, very soon?" the CEO said Q1 2021, which in CEO Safe Harbor talk means "possibly sometime in 2021."

Another 4+ quarters of losses. Another 2+ billion shares dilution. Because they have nothing else - they are putting all their eggs into this basket.

And even then -- even when the product gets on the shelves -- will it sell? After people buy ONE will they come back to buy MORE? It has never happened before in BielCorp's history. Why think it will happen now?

There comes a time when a biotech's rhetoric and Safe Harbor promises no longer suffice -- there comes a time when a biotech either sells the drug/device it developed or fades into oblivion. During the Developmental stage they can keep the BS going indefinitely, stringing everyone along.... but when they get FDA approval/clearance it's time to SELL or admit they can't. This time has come for BielCorp. "Soon" no longer cuts it. They either have to sell the thing NOW or admit they can't sell it.